SALD-7500nano Expands Measurement of Nanoparticles - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

SALD-7500nano Expands Measurement of Nanoparticles

Pharmaceutical Technology
Volume 38, Issue 3, pp. 14

Shimadzu introduces the SALD-7500nano, a particle size analyzer that can measure nanoparticles in low concentrations or those that demonstrate high light absorption. The system is capable of a wide measurement range, from primary particles to sub-visible particles and contaminants, and allows measurements across a concentration range from 0.01 ppm to 20%. It enables measurement of micro bubbles from 100 nm to 60 μm and real-time tracking of changes in bubble diameter. The SALD-7500nano features a single light source and wide-angle detection method, allowing high-speed measurement to a minimum of one second and real-time display of particle size distribution at one-second intervals. The system uses an omnidirectional shock absorption frame to improve instrument stability and provide high reproducibility, while built-in self-diagnostic functions ensure easy maintenance.

Shimadzu Scientific Instruments


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: Pharmaceutical Technology,
Click here